The MGH Center for Precision Psychiatry will be hosting the
Second Annual Conference on Precision Psychiatry: Innovation to Implementation
Event Date: Wednesday, November 2 andThursday, November 3, 2022
The Annual Conference on Precision Psychiatry, hosted by the MGH Center for Precision Psychiatry, is becoming a leading venue for showcasing advances in the application of precision medicine approaches to psychiatric research and clinical practice. The Conference will be held virtually over the course of two days: Wednesday, November 2nd and Thursday, November 3rd, 2022. You can learn more about the conference HERE.
KEYNOTE SPEAKERS
SPEAKERS
Jehannine Austin, PhD – Professor in the Department of Medical Genetics, University of British Columbia; Executive Director, BC Mental Health and Addictions Research Institute
Jennifer Barnett, PhD – Chief Executive Officer, Monument Therapeutics; Chief Scientific Officer, Five Lives; Honorary Research Fellow in Dept. of Psychiatry, University of Cambridge
Chad Bousman, PhD – CEO/Founder, Sequence2Script Inc.; Associate Professor, University of Calgary
Wendy Chung, MD, PhD – Kennedy Family Professor of Pediatrics and Medicine, Columbia University; Precision Medicine Resource Leader, Irving Institute; Medical Director, Columbia Genetic Counseling Graduate Program; Associate Director for Education, Herbert Irving Comprehensive Cancer Center; Chief, Division of Clinical Genetics, Department of Pediatrics
Lea Davis, PhD – Associate Professor of Medicine, Biomedical Informatic, Molecular Physiology & Biophysics, and Psychiatry & Behavioral Sciences, Vanderbilt University Medical Center
Laura Germine, PhD – Director of Brain and Cognitive Health Technology, McLean Hospital; Co-director of the Institute for Technology in Psychiatry, McLean Hospital; Assistant Professor, Harvard Medical School; President and Director, The Many Brains Project
Stephen Haggarty, PhD – Associate Professor of Neurology, Harvard Medical School; Associate Neuroscientist, Massachusetts General Hospital; Director of the MGH Chemical Neurobiology Laboratory at the Center for Genomic Medicine
Oliver Harrison, MA, MBBS, MPH – Founder and Chief Executive Officer, Koa Health; Independent Expert Bank, Wellcome Trust; Roster of Experts- Digital Health, World Health Organization
Yasmin Hurd, PhD – Director of the Addiction Institute, Mount Sinai; Professor, Icahn School of Medicine at Mount Sinai
Scott Kollins, PhD – Chief Medical Officer, Holmusk; Strategic Advisor for Digital Health Solutions, Duke Clinical Research Institute
David Olson, PhD – Chief Innovation Officer and Head of the Scientific Advisory Board, Delix Therapeutics; Associate Professor, University of California Davis
Anthony Philippakis, MD, PhD – Chief Data Officer, Broad Institute of MIT and Harvard; Venture Partner, GV
Katherine Scangos, MD, PhD – Medical Director, Neumora ; Co-Director TMS and Neuromodulation Program, University of California San Francisco
Nigam Shah, PhD – Professor of Medicine, Stanford University; Associate Dean and Professor of Medicine and Biomedical Data Science, Stanford University School of Medicine
Morgan Sheng, PhD – Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
